ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...
Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD; U.S. patent to expire in March 2043, including 1,095 days of Patent Term Adjustment; Notic ...
Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...
Tech Xplore on MSN
Programmable metasurface generates dozens of holograms at once
Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPDU.S. patent to expire in March 2043, including 1,095 days of Patent Term AdjustmentNotice of allowance also recei ...
Top line data readout expected in late Q3/early Q4; INFORM-MS trial is a randomized, double-blind, placebo-controlled Phase ...
When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no ...
Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital ...
Interesting Engineering on MSN
New US motor slashes internal voltage fluctuations by 90% for electric aircraft
Researchers at the Oak Ridge National Laboratory National Transportation Research Center have designed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results